BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/12/2023 8:16:26 AM | Browse: 397 | Download: 1193
 |
Received |
|
2023-03-18 17:30 |
|
Peer-Review Started |
|
2023-03-18 17:32 |
|
First Decision by Editorial Office Director |
|
2023-05-09 08:12 |
|
Return for Revision |
|
2023-05-09 08:12 |
|
Revised |
|
2023-05-09 19:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-05-15 03:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-05-15 08:50 |
|
Articles in Press |
|
2023-05-15 08:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-01 01:26 |
|
Publish the Manuscript Online |
|
2023-06-12 08:16 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Case Control Study |
| Article Title |
Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Eham Amer Ali, Wassan Nori, Alea Farhan Salman, Taghreed S Saeed Al-Rawi, Ban H Hameed and Raid M Al-Ani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Raid M Al-Ani, MBChB, N/A, Academic Editor, Consultant Physician-Scientist, Full Professor, Researcher, Science Editor, Department of Surgery/Otolaryngology, University of Anbar College of Medicine, University of Anbar College of Medicine, Al-Andalus, No. 41 Street, Ramadi City 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq |
| Key Words |
Early onset preeclampsia; Late-onset preeclampsia; Prediction; Elabela; Preeclampsia; Pregnant women |
| Core Tip |
Preeclampsia (PE) is a worldwide cause of increased maternal and perinatal morbidity; PE is divided into early-onset and late-onset subtypes. The precise pathophysiology of PE is obscured, and currently no treatment exists but to terminate pregnancy. Several researches seek a reliable biomarker to anticipate PE to mitigate its negative effects. Elabela (Ela), a recently discovered peptide hormone secreted by the fetus and human placenta; animal studies confirmed Ela’s critical role in maintaining blood pressure; its deficiency was linked to elevated blood pressure. The purpose of this study was to evaluate the accuracy of Ela in predicting PE based on the time of occurrence. |
| Publish Date |
2023-06-12 08:16 |
| Citation |
Amer Ali E, Nori W, Salman AF, Al-Rawi TSS, Hameed BH, Al-Ani RM. Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study. World J Clin Cases 2023; 11(17): 3993-4002 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i17/3993.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i17.3993 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
